We recently sat down with Medisanté‘s CEO, Gilles Lunzenfichter, to talk about Connected Care for Remote Patient Monitoring.
Medisanté empowers connected care by putting the internet of things (IoT) to work for care teams. Its global telehealth device cloud delivers seamless device interoperability across vendor and country silos.
It connects direct-to-cloud a broad range of medical devices instead of relying on mobile apps on smartphones and many APIs from proprietary device clouds.
This new way to collect vital signs in Remote Patient Monitoring (RPM) and Decentralized Clinical Trials (DCT) has 3 major advantages for modern health IT system providers and their HCLS clients:
- A device assignment in a compliant health IT system enables privacy and security by design instead of adding vulnerabilities on edge in the home.
- A zero-touch device configuration enables the inclusion of patients most in need of virtual care regardless of their social determinants of health.
- Vendor-agnostic device management enables technical teams to keep device deployment simple and secure at scale for care teams and patients.
A few topics discussed:
- The importance of seamless device interoperability with health IT systems in remote patient monitoring (RPM). The myth that the device connectivity of the future will rely on device vendors’ mobile apps on the consumer smartphone is about to be dispelled.
- “App2cloud” cellular device connectivity in the home is a major source of vulnerability to cyberattacks and ransomware in RPM. In addition, health care systems and data protection officers at providers cannot afford the risk of having a clunky end-point to automate IoT data collection in population health.
- The emergence of modern health IT systems designed to be systems of inter-action with remote patients instead of being systems that “record” in-person encounters in hospitals are a key trend towards virtual chronic care. Such systems will be both compliant AND cloud-enabled, in case there is still any doubt there.
- The shift in national health care reimbursement policies in Europe towards virtual care is no longer a matter of “if” but only of “when.” It might still take 5-10 years, though, for laggard countries to make drastic changes vs. the most innovative ones that invest in virtual care now. However, in life sciences, the shift to Decentralized Clinical Trials (DCT) will happen faster.
Medisanté is headquartered in Switzerland and is an innovation champion in the Personal Connected Health Alliance, where it chairs the direct-to-cloud workgroup. Its global direct-to-cloud medical IoT infrastructure radically simplifies the integration of Patient-Generated Health Data (PGHD) into clinical systems. It combines the best global tech for anonymous device data with the best healthcare privacy for sensitive patient data. By abstracting hardware complexity and diversity in the patient’s home, Medisanté allows Remote Patient Monitoring (RPM) to scale anywhere in the world. It makes it easy for care teams, bio-medical engineers, and patients at the same time. Easy always wins!